Current use of ECT in the treatment of depressive disorders;Zur behandlung depressiver störungen mit modernen verfahren der elektrokonvulsionstherapie

Fortschritte der Neurologie Psychiatrie

Volumn 70, Issue 7, 2002, Pages 353-367

  Klecha, D ^a   Legler, M ^a   Hull M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; ELECTROCONVULSIVE THERAPY; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MONITORING; RANDOMIZED CONTROLLED TRIAL; SAFETY; TREATMENT INDICATION; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; GERMANY; HUMANS; PROGNOSIS;

EID: 0036328282     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-32520     Document Type: Article

References (118)

1. Die einführung der schockbehandlungen und die psychiatrische emigration
2. Convulsive therapy: A review of the first 55 years
3. Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs
4. Der stellenwert der EKT bei therapieresistenten depressionen
5. Affektive erkrankungen
6. The efficacy of electroconvulsive therapy
7. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
8. Comparison of the therapeutic efficacy of ECT and imipramine: A randomized controlled trial
9. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: A randomized comparison with electroconvulsive therapy (ECT) and imipramine
10. The treatment of psychotic depression in later life: A comparison of pharmacotherapy and ECT
11. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression - A randomized study
12. Mood disorders
13. Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park Trials
14. Prediction of ECT response: Validation of a refined sign-based (CORE) system for defining melancholia
15. Which depressed patients respond to ECT? The Nottingham results
16. Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment
17. Acute efficacy of ECT in the treatment of major depression in the old-old
18. Does age predict long-term outcome of depression treated with ECT? (a prospective study of the long-term outcome of ECT-treated depression with respect to age)
19. Speed of response to bilateral ECT: An examination of possible predictors in two controlled trials
20. Polysomnographic studies in patients referred for ECT: Pre-ECT studies
21. Does neuroanatomy predict ECT response?
22. Response to first ECT in depression: A predictor of outcome?
23. Prediction of antidepressant efficacy from response to the first ECT
24. Stimulus dosing methods in electroconvulsive therapy
25. Pulse with and frequency of ECT
26. Efficiency of the stimulus characteristics of ECT
27. ECT stimulus parameters as determinants of seizure quality
28. A comparison of brief and ultrabrief pulse stimuli in unilateral ECT
29. Debate on ECT use in depression continues
30. Stimulus dose-titration in ECT: A 2-year clinical experience
31. Proposed titration schedule
32. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities
33. Electrode placement and electroconvulsive therapy: The search for the chimera
34. Energy dosing in ECT: Threshold stimulation or formula?
35. Stimulus dosing with ECT: To titrate or not to titrate - That is the question
36. The "half-age" stimulation strategy for ECT dosing
37. Seizure threshold estimation by formula method: A prospective study in unilateral ECT
38. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy
39. Convulsive threshold differences in right unilateral and bilateral ECT
40. Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT
41. Clinical predictors of seizure threshold in bilateral ECT
42. Predicting seizure threshold at first ECT: A discriminant analysis study
43. The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: An intraindividual crossover study
44. EEG manifestations during ECT: Effects of electrode placement and stimulus intensity
45. Stimulus intensity, seizure threshold, and seizure duration: Impact on the efficacy and safety of electroconvulsive therapy
46. ECT seizure therapeutic adequacy
47. The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT
48. Is postictal silence a predictor of response to electroconvulsive therapy?
49. Post-seizure EEG fractal dimension of first ECT predicts antidepressant response at two weeks
50. Assessment of the therapeutic adequacy of the ECT seizure: Current status
51. Comparison of bifrontal and bitemporal ECT for major depression
52. ECT stimulus intensity: Are present ECT devices too limited?
53. Twice versus thrice weekly ECT in melancholia: A double-blind prospective comparison
54. Cost and benefit in the choice of ECT schedule
55. A trial to determine any difference between two and three times a week ECT in the rate of recovery from depression
56. The mortality rate with ECT
57. Fatal myocardial infarction and use of psychotropic drugs
58. Antihypertensiva
59. ECT in patients with major depressive disorder and low cardiac output
60. Pro- and anticonvulsant effects of anesthetics (Part II)
61. Epilepsie
62. Intravenöse anästhetika
63. Psychiatrie
64. Propofol reduces seizure duration in patients having anesthesia for electroconvulsive therapy
65. Propofol anesthesia in ECT
66. Muskelrelaxantien - Pharmakologie und klinischer einsatz
67. Does ECT alter brain structure?
68. The hippocampus in patients treated with electroconvulsive therapy: A proton magnetic resonance spectroscopic imaging study
69. Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures
70. Increased neurogenesis in a model of electroconvulsive therapy
71. Molecular and cellular actions of chronic electroconvulsive therapy
72. The effect of medications on ECT
73. Relapse and recurrence following a course of ECT: Reasons for concern and strategies for further investigation
74. Combining ECT and antidepressants: Time to reassess
75. Discontinuation of antidepressant medications before ECT
76. Do SSRIs prolong seizure duration during ECT?
77. Combined ECT and antidepressant drug therapy
78. Electroconvulsive therapy and cardiovascular complications in patients taking Trazodone for insomnia
79. Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT
80. Triazolam and diphenhydramine effects on seizure duration in depressed patients receiving ECT
81. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient
82. Combining ECTand antipsychotic agents: Benefits and risks
83. Safety and efficacy of caffeine-augmented ECT in elderly depressives: A retrospective study
84. The effect of electroconvulsive therapy on memory of autobiographical and public events
85. Subjective memory complaints prior and following electroconvulsive therapy
86. Subjective memory complaints: A review of patient self-assessment of memory after electroconvulsive therapy
87. Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder
88. The pre-ECT evaluation
89. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. A randomized controlled trial
90. Continuation therapy following ECT: Directions for future research
91. Continuation ECT: A review
92. The impact of medication resistence and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression
93. Medication resistance, response to ECT, and prevention of relapse
94. Continuation ECT: Relapse prevention in affective disorders
95. Continuation therapy for depression using outpatient electroconvulsive therapy
96. Continuation and maintenance ECT-efficacy and safety
97. Outpatient electroconvulsive therapy: Efficacy and safety
98. Maintenance ECT: Indications and outcome
99. Maintenance electroconvulsive therapy for geriatric depression: A one year follow-up
100. Cost-effective maintenance treatment of resistant geriatric depression
101. A naturalistic review of maintenance ECT at a university setting
102. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients
103. Maintenance electroconvulsive therapy in affective and schizoaffective disorder
104. Relapse prevention in major depressive disorder after successful ECT. A literature review and a naturalistic case series
105. A second quiet revolution: Ambulatory ECT
106. Maintenance ECT in intractable manic-depressives disorders
107. Cost effectiveness of maintenance ECT